Innovative therapies demand extraordinary means. With an international team of renowned scientists, proven competence in clinical development, and a global network of experts and reliable partners, we differentiate our pipeline by using an indication-driven, technology-agnostic approach. As innovator for antiviral and antibacterial therapies, we target indications with high medical need today (unmet need) and prepare for future threats (pandemic and resistance emergency preparedness - PREP).


Our Pipeline

Innovative solutions for serious infectious diseases.



A flexible and scalable, drug engine


With the experience of big pharma but the flexibility and scalability of a small biotech, AiCuris is driven by scientific expertise and active choice of indication. Our highly qualified in‐house experts collaborate with a wide array of academic and business partners. This enables us access to various technologies, platforms and sub-contractors – each time selected according to project needs.